Evidence map›Paper›PMID 41956436›Full record

ArticleJournal of the American Medical Directors Association2026

Patterns of Daily Administration of Psychoactive Drug Classes for Distress Behavior in Dementia.

Kenneth S Boockvar, Tianwen Huan, Kimberly Curyto, Sei J Lee, Orna Intrator

Abstract read
In one paragraph

Article in Journal of the American Medical Directors Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kenneth S BoockvarDivision of Gerontology, Geriatrics, and Palliative Care, University of Alabama, Birmingham, AL, USA; Geriatrics Research, Education, and Clinical Center, Birmingham VA Health Care System, Birmingham, AL, USA; Research Institute on Aging, The New Jewish Home, New York, NY, USA. Electronic address: kboockvar@uabmc.edu.
Tianwen HuanDepartment of Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; VA Geriatrics & Extended Care Data Analysis Center, James J Peters VA Medical Center, Bronx, NY, USA.
Kimberly CurytoVA Western New York Healthcare System, Center for Integrated Healthcare, Buffalo, NY, USA.
Sei J LeeDivision of Geriatrics, University of California, San Francisco, CA, USA; San Francisco VA Health Care System, San Francisco, CA, USA.
Orna IntratorResearch Institute on Aging, The New Jewish Home, New York, NY, USA; Department of Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA; VA Geriatrics & Extended Care Data Analysis Center, James J Peters VA Medical Center, Bronx, NY, USA; Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Funding

Mentoring Patient-Oriented Research to Individualize Care for Hospitalized Older Adults with and without Alzheimer's Disease and Related DementiasK24AG066998 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sei Lee · 2021 to 2026
$1.1M
Behavioral and psychological symptoms of dementia and hypertension in nursing home residentsR21AG068612 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BOOCKVAR, KENNETH S., INTRATOR, ORNA K. · 2020 to 2020
$359k
NIA NIH HHS K24 AG066998NIA NIH HHS R21 AG068612
6 · The paper itself

Abstract

objectivesDistress behaviors in dementia (DBDs) are common, are a significant burden to patients, families, and caregivers, and decrease quality of life. Despite risks, many nursing home (NH) residents are prescribed ≥ 1 classes of psychoactive medications for DBD. The objective of this study was to examine daily use of 4 classes of psychoactive medication in NH residents with DBD.

designThis was a retrospective longitudinal cohort study. SETTING AND

participantsParticipants included long-stay Veterans Affairs NH residents with dementia in 2019-2020, with and without DBD.

methodsWe identified daily use of antipsychotics, benzodiazepines, antidepressants, and antiepileptics, identified from bar-coded administration data, from 30 days prior to 30 days after a documented DBD incident. We estimated multivariate associations between resident characteristics and administration of selected classes of medication on the DBD incident day, accounting for prior class use.

resultsThe DBD and comparison groups consisted of 974 and 1138 individuals, respectively. Overall, the groups were 76 years old on average, and 14% had severe cognitive impairment. Administration of antipsychotic and benzodiazepine medication rose slightly 3 to 7 days before the DBD incident day, followed by sharp rises in administration on the DBD incident day, and sharp declines the next day. Increases in both classes persisted 30 days after the DBD incident day. None of these changes were observed in the comparison group. There were associations between benzodiazepine and antipsychotic administration and mental health conditions, and an inverse association between benzodiazepine administration and recent past gabapentin receipt. CONCLUSIONS AND IMPLICATIONS: Patterns of psychoactive medication administration varied among drug classes, but were linked across drug classes. Efforts to reduce prescribing of these medications need to be designed to take into account multiple classes of medication and target early signs of distress behavior.

Indexed as

DementiaPsychotropic DrugsAgedAged, 80 and overAntidepressive AgentsAntipsychotic AgentsBenzodiazepinesFemaleHumansLongitudinal StudiesMaleNursing Home ResidentsRetrospective StudiesUnited StatesAntidepressive AgentsAntipsychotic AgentsBenzodiazepinesPsychotropic Drugsbehavioral symptomsDementiapsychotropic drugs

Identifiers

PMID41956436
PMCPMC13292614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.